FFAFX | USLIX | FFAFX / USLIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 4 years | 23 years | - |
Gain YTD | 20.943 | 5.667 | 370% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 250000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 301B | 2.03B | 14,828% |
Annual Yield % from dividends | 0.70 | 0.00 | - |
Returns for 1 year | 21.17 | 6.08 | 349% |
Returns for 3 years | 4.09 | -3.28 | -125% |
Returns for 5 years | N/A | 31.40 | - |
Returns for 10 years | N/A | 73.17 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
NQGIX | 34.77 | 0.24 | +0.70% |
Nuveen Global Equity Income I | |||
NSFDX | 9.47 | 0.01 | +0.11% |
Natixis Target Retirement 2020 N | |||
GSVTX | 15.86 | N/A | N/A |
Goldman Sachs Large Cap Value Inv | |||
FCDAX | 35.98 | -0.01 | -0.03% |
Fidelity Advisor Stock Selector Sm Cp A | |||
ETNHX | 32.82 | -0.05 | -0.15% |
Eventide Healthcare & Life Sciences N |